Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Infection01:20

Infection

11.6K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.6K
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

524
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
524
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

676
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
676
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K
Stages of Infection01:26

Stages of Infection

64.7K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
64.7K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

2.6K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.6K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Safe focused ultrasound-mediated blood-brain barrier opening is driven primarily by transient reorganization of tight junctions.

Communications engineering·2026
Same author

Rab7a is required to degrade select blood-brain barrier junctional proteins after ischemic stroke.

Acta neuropathologica communications·2025
Same author

Dietary flavonoids form supramolecular assemblies, alter biochemistry, and enhance cell resilience.

Frontiers in nutrition·2025
Same author

Safe focused ultrasound-mediated blood-brain barrier opening is driven primarily by transient reorganization of tight junctions.

Research square·2025
Same author

Safe focused ultrasound-mediated blood-brain barrier opening is driven primarily by transient reorganization of tight junctions.

bioRxiv : the preprint server for biology·2025
Same author

Cervical mucus in linked human Cervix and Vagina Chips modulates vaginal dysbiosis.

npj women's health·2025
Same journal

Breaking barriers: Enhancing access to dementia clinical trials in the United Kingdom-Insights from the Scientific Advisory Board of the Dame Barbara Windsor Dementia Goals Programme.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Jan 8, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
09:07

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

11.5K

Ciencia básica y patogénesis

Ana R Santa-Maria1, Sanjid Shahriar1

  • 1Wyss Institute at Harvard University, Boston, MA, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
Resumen
Este resumen es generado por máquina.

La administración de fármacos en el cerebro se enfrenta a los desafíos de la barrera hematoencefálica (BHE). Este estudio encontró que la variación biológica individual, no la demografía, afecta la expresión del objetivo del fármaco, lo que sugiere la medicina personalizada para las fusiones de fármacos transportadores en el cerebro.

Palabras clave:
barrera hematoencefálicamedicina personalizadaexpresión de proteínasneurocienciaadministración de fármacos en el cerebro

Más Videos Relacionados

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
13:45

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia

Published on: September 21, 2019

6.0K
Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
08:38

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses

Published on: February 22, 2019

6.3K

Videos de Experimentos Relacionados

Last Updated: Jan 8, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
09:07

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

11.5K
A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
13:45

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia

Published on: September 21, 2019

6.0K
Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
08:38

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses

Published on: February 22, 2019

6.3K

Área de la Ciencia:

  • Neurociencia
  • Farmacología
  • Biotecnología

Sus antecedentes:

  • La barrera hematoencefálica (BHE) restringe la administración de fármacos al cerebro, lo que requiere métodos de transporte avanzados.
  • Los transportadores cerebrales mejoran la captación terapéutica, pero su eficacia depende de la expresión del receptor diana.
  • Comprender la variabilidad de la expresión del receptor diana es crucial para desarrollar fusiones eficaces de fármacos transportadores en el cerebro.

Objetivo del estudio:

  • Analizar la variación en la expresión de la diana de transporte en diferentes regiones cerebrales, estados de la enfermedad, géneros y grupos de edad.
  • Investigar cómo los factores demográficos y la neuropatología influyen en la expresión de las dianas farmacológicas para las fusiones de fármacos transportadores en el cerebro.
  • Identificar biomarcadores potenciales para predecir la captación de fármacos en el cerebro.

Principales métodos:

  • Desarrollo de un pipeline bioinformático utilizando datos de secuenciación de ARN de célula/núcleo única (RNA-Seq) y proteómicos.
  • Análisis de la expresión de proteínas de superficie en células endoteliales microvasculares cerebrales.
  • Realización de análisis de correlación en regiones cerebrales y estados de la enfermedad, incluida la enfermedad de Alzheimer (EA), centrándose en el género y el envejecimiento.

Principales resultados:

  • Los factores demográficos (región cerebral, estado de la enfermedad, género, envejecimiento) no alteraron significativamente la expresión del transcrito o la proteína diana.
  • Se observó una variación individual sustancial en la expresión de la diana dentro de las cohortes demográficas, independientemente de la EA.
  • Las diferencias biológicas individuales, en lugar de los datos demográficos, parecen influir en la expresión de la diana del fármaco.

Conclusiones:

  • La variación individual en la expresión del receptor de transporte puede servir como biomarcador para predecir la captación de fármacos.
  • Se planean futuros estudios utilizando modelos murinos con niveles de receptores controlados.
  • Los hallazgos pueden informar enfoques de medicina personalizada para la selección de pacientes para tratamientos con fármacos de fusión.